PL2787841T3 - Peptydy beta-laktoglobuliny do leczenia alergii na białko mleka krowiego - Google Patents

Peptydy beta-laktoglobuliny do leczenia alergii na białko mleka krowiego

Info

Publication number
PL2787841T3
PL2787841T3 PL12795467T PL12795467T PL2787841T3 PL 2787841 T3 PL2787841 T3 PL 2787841T3 PL 12795467 T PL12795467 T PL 12795467T PL 12795467 T PL12795467 T PL 12795467T PL 2787841 T3 PL2787841 T3 PL 2787841T3
Authority
PL
Poland
Prior art keywords
beta
milk protein
protein allergy
treating cow
lactoglobulin peptides
Prior art date
Application number
PL12795467T
Other languages
English (en)
Inventor
Léon Mathieu Johannes Knippels
Johan Garssen
Laura Antoinette Petronella Maria Meulenbroek
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL2787841T3 publication Critical patent/PL2787841T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL12795467T 2011-12-07 2012-12-06 Peptydy beta-laktoglobuliny do leczenia alergii na białko mleka krowiego PL2787841T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2011/006148 WO2013083140A1 (en) 2011-12-07 2011-12-07 Beta-lactoglobulin peptides for treating cow's milk protein allergy
PCT/EP2012/074639 WO2013083691A1 (en) 2011-12-07 2012-12-06 Beta-lactoglobulin peptides for treating cow's milk protein allergy
EP12795467.5A EP2787841B1 (en) 2011-12-07 2012-12-06 Beta-lactoglobulin peptides for treating cow's milk protein allergy

Publications (1)

Publication Number Publication Date
PL2787841T3 true PL2787841T3 (pl) 2018-02-28

Family

ID=47291006

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12795467T PL2787841T3 (pl) 2011-12-07 2012-12-06 Peptydy beta-laktoglobuliny do leczenia alergii na białko mleka krowiego
PL16187809T PL3135125T3 (pl) 2011-12-07 2012-12-06 Peptydy beta-laktoglobulinowe do leczenia alergii na białko mleka krowiego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL16187809T PL3135125T3 (pl) 2011-12-07 2012-12-06 Peptydy beta-laktoglobulinowe do leczenia alergii na białko mleka krowiego

Country Status (8)

Country Link
US (1) US9555103B2 (pl)
EP (2) EP2787841B1 (pl)
CN (2) CN107853697A (pl)
DK (1) DK2787841T3 (pl)
ES (2) ES2652663T3 (pl)
HU (1) HUE037608T2 (pl)
PL (2) PL2787841T3 (pl)
WO (2) WO2013083140A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP3338565A1 (en) * 2010-06-04 2018-06-27 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
US9603927B2 (en) 2014-02-28 2017-03-28 Janssen Biotech, Inc. Combination therapies with anti-CD38 antibodies
US9732154B2 (en) 2014-02-28 2017-08-15 Janssen Biotech, Inc. Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
WO2016013928A1 (en) * 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
CN107406506A (zh) 2014-12-04 2017-11-28 詹森生物科技公司 用于治疗急性髓系白血病的抗cd38抗体
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
EA201792546A1 (ru) 2015-05-20 2018-04-30 Янссен Байотек, Инк. Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей
US10500179B2 (en) * 2015-10-02 2019-12-10 N. V. Nutricia Glycine for use in tolerance induction in allergic patients
CA3004152C (en) 2015-11-03 2024-04-16 Janssen Biotech, Inc. Subcutaneous formulations of anti-cd38 antibodies and their uses
WO2017144730A1 (en) * 2016-02-26 2017-08-31 Danmarks Tekniske Universitet Milk allergy prevention and treatment
US20190233533A1 (en) 2016-06-28 2019-08-01 Umc Utrecht Holding B.V. Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
MA50514A (fr) 2017-10-31 2020-09-09 Janssen Biotech Inc Méthodes de traitement du myélome multiple à haut risque
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
WO2019212330A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
WO2021091369A1 (en) * 2019-11-07 2021-05-14 N.V. Nutricia Extensive whey protein hydrolysate with tolerogenic peptides
CN112694516A (zh) * 2020-12-10 2021-04-23 重庆大学 一种可降低牛乳β乳球蛋白致敏的多肽
WO2022184772A1 (en) * 2021-03-02 2022-09-09 Arla Foods Amba Immunogenic protein hydrolysate with reduced allergenicity
CN114149484B (zh) * 2021-05-28 2023-06-06 中国科学院大连化学物理研究所 一种抗菌肽mamp-03及其应用
WO2023221994A1 (zh) * 2022-05-17 2023-11-23 上海昌进生物科技有限公司 一种乳蛋白组合物及其制备方法和应用
WO2025128638A1 (en) * 2023-12-15 2025-06-19 La Jolla Institute For Immunology Cow milk allergen epitopes, megapools and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
PT827697E (pt) 1996-09-06 2002-11-29 Nestle Sa Inducao da tolerancia ao leite de vaca
MY129566A (en) 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
IL154284A0 (en) * 2000-09-25 2003-09-17 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
US7052916B2 (en) * 2002-05-24 2006-05-30 Immunex Corporation Polypeptide analyses using stable isotope labeling
US20050175759A1 (en) * 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
ES2488128T5 (es) * 2005-04-27 2022-11-15 Nutricia Nv Nutrición con lípidos y sacáridos no digeribles
CN101212911B (zh) * 2005-07-01 2012-12-05 努特里希亚公司 含水解的蛋白质的婴儿营养品
ES2709176T3 (es) 2006-08-11 2019-04-15 Life Sciences Res Partners Vzw Péptidos inmunogénicos y su uso en trastornos inmunitarios
JP2010105915A (ja) * 2006-11-19 2010-05-13 Icreo Co Ltd ペプチド組成物
US20090297545A1 (en) * 2008-05-27 2009-12-03 Universite Laval Immunomodulatory dairy peptides and uses thereof
WO2010052939A1 (ja) * 2008-11-10 2010-05-14 国立大学法人名古屋大学 アレルゲンのエピトープ又はその候補の検出方法及びその利用
ES2524067T3 (es) 2009-12-04 2014-12-03 Mjn U.S. Holdings Llc Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia
JP6026720B2 (ja) * 2009-12-18 2016-11-16 株式会社明治 血糖値降下剤及び血糖値降下飲食品組成物

Also Published As

Publication number Publication date
CN104039173A (zh) 2014-09-10
WO2013083140A1 (en) 2013-06-13
ES2652663T3 (es) 2018-02-05
CN107853697A (zh) 2018-03-30
DK2787841T3 (da) 2017-11-13
EP2787841A1 (en) 2014-10-15
ES2791288T3 (es) 2020-11-03
US9555103B2 (en) 2017-01-31
PL3135125T3 (pl) 2020-08-10
EP3135125B1 (en) 2020-02-19
WO2013083691A1 (en) 2013-06-13
HUE037608T2 (hu) 2018-09-28
EP2787841B1 (en) 2017-10-04
US20140314800A1 (en) 2014-10-23
EP3135125A1 (en) 2017-03-01

Similar Documents

Publication Publication Date Title
HUE037608T2 (hu) Béta-laktoglobulin peptidek tehéntejfehérje-allergia kezelésére
IL279676A (en) Recombinant proteins and therapeutic uses
IL232073A0 (en) Recombinant human naglu protein and its uses
IL231647A0 (en) Proteins with dual activity for the treatment of metabolic disorders
IL231604B (en) Therapeutic peptides
ZA201400562B (en) Axmi205 variant proteins and methods for their use
PL2768848T3 (pl) Środki i sposoby ekspresji i wydzielania peptydów i białek
PL2714902T3 (pl) Wektory ekspresyjne do polepszonej sekrecji białka
SMT202000087T1 (it) Pellicole rivestite con proteina di siero di latte
PL2668205T3 (pl) Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie
EP2792361A4 (en) MEDICAL COMPOSITION FOR PREVENTING OR TREATING AMYLOID-BETA-PEPTIDE-MEDIATED DISEASES OR SUFFERING
IL206528A (en) Process for making concentrated soy protein
EP2610349A4 (en) FULL-PIPES, PREPARATION AND USE
EP2598636A4 (en) VECTORS AND METHODS FOR EXPRESSION OF RECOMBINANT PROTEINS
ZA201208744B (en) Casein peptide for use in the treatment of uterine infections
IL231715A (en) Liquid protein supplement that has been sterilized
EP2773959A4 (en) FRACTIONATION OF PROTEINS ACCORDING TO THEIR ISOELECTRIC POINT
EP2730176A4 (en) TASTE-IMPROVING PEPTIDE
EP2616485A4 (en) STEPPED DEVELOPED PEPTIDE FOR THE TREATMENT OF BRAIN INJURIES
IL239078A0 (en) Protein for use in the treatment of eye diseases
EP3054300A4 (en) Method for prognosis of the efficacy of oral immunotherapy for the treatment of allergy to proteins in cow's milk
ZA201504016B (en) Biocomposite materials derived from animal protein
IL222521A0 (en) Casein peptide for use in the treatment of uterine infections
GB201113089D0 (en) Protein hydrolysates
GB0921430D0 (en) Protein for therapeutic use